8:30 a.m.

Welcome, Introductions, and Context

George Isham, senior advisor, HealthPartners; senior fellow, HealthPartners Institute for Education and Research; co-chair, Roundtable on Population Health Improvement

8:40 a.m.

Welcome to the New York Academy of Medicine

Jo Ivey Boufford, president, New York Academy of Medicine

8:50 a.m.

Keynote Presentation

Dan Buettner, founder, Blue Zones^®

9:20 a.m.

Discussion

9:45 a.m.

Panel I: The Case for Engagement in Population Health Improvement

This panel will provide a broad view of the reasons and approaches for business involvement in population health improvement. Reasons may include alignment with core company values and broader company priorities such as safety, human capital, corporate reputation, sustainability, corporate social responsibility, and return on investment. Approaches may include philanthropy, leadership influence, board roles, and advocacy.

Moderator: Andrew Webber, chief executive officer, Maine Health Management Coalition; member, Roundtable on Population Health Improvement; member, workshop planning committee

Michael O’Donnell, director, Health Management Research Center, University of Michigan

Catherine Baase, chief health officer, The Dow Chemical Company; member, Roundtable on Population Health Improvement; member, workshop planning committee

Nicolaas Pronk, vice president and chief science officer, HealthPartners

10:20 a.m.

Discussion

10:45 a.m.

Break

11:00 a.m.

Panel II: What Business Actions Make an Impact on Population Health?

This panel will focus on community health improvement projects that may not have improving health as the main goal but which do impact social and other determinants that affect population health improvement. Panelists will be asked to describe both the corporate priority that drove the action/aim of the program (e.g., early childhood education, building green space, improving transportation) and, briefly, the strategy they used (e.g., philanthropy, multi-stakeholder activity).

Moderator: Catherine Baase, chief health officer, The Dow Chemical Company; member, Roundtable on Population Health Improvement; member, workshop planning committee

Gary Rost, executive director, Savannah Business Group

Grace Suh, manager, Education, Corporate Citizenship & Corporate Affairs, IBM Corporation

Alisa May, executive director, Priority Spokane

11:35 a.m.

Discussion

12:15 p.m.

Lunch

1:15 p.m.

Panel III: Community/Population Health as an Intentional Business Strategy

This panel will focus on business strategies, actions, and impacts that were intentionally designed to improve population health.

Moderator: James Knickman, president and chief executive officer, New York State Health Foundation; member, Roundtable on Population Health Improvement; member, workshop planning committee

Fikry Isaac, vice president, global health services, Johnson & Johnson

Charles Yarborough, director of medical strategies, Lockheed Martin

1:50 p.m.

Discussion

2:30 p.m.

Panel IV: How Can Business Engage?

This panel will focus on frameworks or mechanisms that work well to stimulate and support business engagement in population health improvement.

Moderator: Alex Chan, Clinton Foundation fellow

George Isham, senior advisor, HealthPartners; senior fellow, HealthPartners Institute for Education and Research; co-chair, Roundtable on Population Health Improvement; member, workshop planning committee

Neil Goldfarb, Greater Philadelphia Business Coalition on Health

John Whittington, Institute for Healthcare Improvement

3:15 p.m.

Break

3:30 p.m.

Discussion of Previous Panel

4:00 p.m.

Reflections on the Day

Moderator: David Kindig, professor emeritus of population health sciences, emeritus vice chancellor for health sciences, University of Wisconsin School of Medicine and Public Health; co-chair, Roundtable on Population Health Improvement

4:45 p.m.

Open Discussion

5:15 p.m.

Adjourn

For more information about the roundtable, visit www.iom.edu/pophealthrt or email pophealthrt@nas.edu.